Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure and a Left Ventricular Assist Device

NCT00534703 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00534703
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00534703 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of the Safety and Feasibility of AAV1/SERCA2a Gene Transfer in Patients With Chronic Heart Failure and a Left Ventricular Assist Device
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2014
Completion date
September 30, 2015
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure, patients that have received a left ventricular assist device